Niox Group (NIOX)

Sector:

Health Care

Index:

FTSE AIM 50

65.60p
   
  • Change Today:
    -2.00p
  • 52 Week High: 76.00
  • 52 Week Low: 54.60
  • Currency: UK Pounds
  • Shares Issued: 399.36m
  • Volume: 557,154
  • Market Cap: £261.98m

Niox Group Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Key Personnel

CEO: Jonathan Emms
Chief Finance Officer: Michael R D Roller
Executive Chairman: Ian Johnson
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Sharon Curran
Senior Independent Director: Garry Watts
Non-Executive Dir: Nicholas Mills, Robert (Rob) Graham Naylor

Contact Details

Address: Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB
Phone: +44 (0)1865 405560
Fax: +44 (0)7092 987560
Website: http://www.niox.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 50, FTSE AIM 100
Overseas Listings: BATSLON:CIRL
ISIN: GB00BJVD3B28

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Niox Group Market Data

Currency UK Pounds
Share Price 65.60p
Change Today -2.00p
% Change -2.96 %
52 Week High 76.00
52 Week Low 54.60
Volume 557,154
Shares Issued 399.36m
Market Cap £261.98m

Niox Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.17% below the market average71.17% below the market average71.17% below the market average71.17% below the market average71.17% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
43.23% above the market average43.23% above the market average43.23% above the market average43.23% above the market average43.23% above the market average
62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average62.16% above the sector average
Income
81.28% below the market average81.28% below the market average81.28% below the market average81.28% below the market average81.28% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.27% above the market average34.27% above the market average34.27% above the market average34.27% above the market average34.27% above the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Niox Group Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 23-May-24
Paid 16-Jun-25 24-Jun-24
Amount 1.25p 1.00p

Trades for 08-May-2025

Time Volume / Share Price
16:35 43,098 @ 65.60p
16:35 634 @ 65.60p
16:35 572 @ 65.60p
16:35 572 @ 65.60p
16:35 588 @ 65.60p

Niox Group Key Personnel

CEO Jonathan Emms

Top of Page